ImaBiotech website in English


  • ASMS 2017

    Come and meet Rima Ait-Belkacem and Jonathan Stauber to discover all our capabilities. June 4- 8, 2017, in (...)

    Read more
  • Webinar on Immuno-Oncology by Rima AIT-BELKACEM, PhD

    The webinar titled “Immuno-Oncology: Tryptophan-Kynurenine Microenvironment Tumor Metabolites Pathway Highlighted by (...)

    Read more
See all news

HD Screening

Study Drug distribution at early stage to select best drug candidates : Screen your molecules, Faster, Better and Cheaper.

ImaBiotech developed a new way to screen your molecules. MALDI Imaging Mass Spectrometry technologies are perfectly suitable for drug candidates screening. Indeed quick study initiation allows obtaining the distribution comparison of different drug candidates at different time points per organ (whole-body section) or per histological region (single organ). This precious information allows to quickly identify or/and optimize a drug candidate.

Screening Studies Molecules metabolites distribution

  • 2 weeks - 20 drugs and metabolites distribution
  • Organs or Whole body distributions
  • Faster than classical methods

    Tissues samples
  • Necropsy
  • Biopsy
  • Whole body